<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font10 { font-size : 10; } .font27 { font-size : 27; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font27">and </span>
   <span class="font17">for </span>
   <span class="font13">are </span>
   <span class="font12">The </span>
   <span class="font12">risk </span>
   <span class="font12">NBMs </span>
   <span class="font11">can </span>
   <span class="font11">from </span>
   <span class="font11">with </span>
   <span class="font11">that </span>
   <span class="font11">assessment </span>
   <span class="font11">[]. </span>
   <span class="font11">risks </span>
   <span class="font11">data </span>
   <span class="font11">(e.g., </span>
   <span class="font11">exposure </span>
   <span class="font11">European </span>
   <span class="font11">also </span>
   <span class="font11">management </span>
   <span class="font11">environmental </span>
   <span class="font11">used </span>
   <span class="font11">use </span>
   <span class="font10">Assessment </span>
   <span class="font10">Risk </span>
   <span class="font10">these </span>
   <span class="font10">their </span>
   <span class="font10">have </span>
   <span class="font10">regulatory </span>
   <span class="font10">safety </span>
   <span class="font10">medical </span>
   <span class="font10">.collab: </span>
   <span class="font10">process </span>
   <span class="font10">{background </span>
   <span class="font10">analysis </span>
   <span class="font10">materials </span>
   <span class="font10">NBM </span>
   <span class="font10">RMF </span>
   <span class="font10">relevant </span>
   <span class="font10">testing </span>
   <span class="font10">not </span>
   <span class="font10">such </span>
   <span class="font10">which </span>
   <span class="font10">Safety </span>
   <span class="font10">based </span>
   <span class="font10">different </span>
   <span class="font10">should </span>
   <span class="font10">been </span>
   <span class="font10">BIORIMA </span>
   <span class="font10">This </span>
   <span class="font10">control </span>
   <span class="font10">hazard </span>
   <span class="font10">this </span>
   <span class="font10">during </span>
   <span class="font10">framework </span>
   <span class="font10">has </span>
   <span class="font10">information </span>
   <span class="font10">life </span>
   <span class="font10">measures </span>
   <span class="font10">vitro </span>
   <span class="font10">ATMP </span>
   <span class="font10">These </span>
   <span class="font10">approaches </span>
   <span class="font10">margin </span>
   <span class="font10">specific </span>
   <span class="font10">models </span>
   <span class="font10">{border-style </span>
   <span class="font10">clinical </span>
   <span class="font10">cycle </span>
   <span class="font10">development </span>
   <span class="font10">methods </span>
   <span class="font10">need </span>
   <span class="font10">possible </span>
   <span class="font10">product </span>
   <span class="font10">manufacturing </span>
   <span class="font10">products </span>
   <span class="font10">px;} </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">Environmental </span>
   <span class="font10">approach </span>
   <span class="font10">occupational </span>
   <span class="font10">there </span>
   <span class="font10">vivo </span>
   <span class="font10">while </span>
   <span class="font10">Benefit-Risk </span>
   <span class="font10">Engineered </span>
   <span class="font10">Management </span>
   <span class="font10">Medical </span>
   <span class="font10">Medicines </span>
   <span class="font10">Nanomaterials </span>
   <span class="font10">benefit </span>
   <span class="font10">benefits </span>
   <span class="font10">both </span>
   <span class="font10">Drug </span>
   <span class="font10">Health </span>
   <span class="font10">[,]. </span>
   <span class="font10">and/or </span>
   <span class="font10">healthcare </span>
   <span class="font10">patients </span>
   <span class="font10">research </span>
   <span class="font10">well </span>
   <span class="font10">Agency </span>
   <span class="font10">available </span>
   <span class="font10">but </span>
   <span class="font10">developed </span>
   <span class="font10">including </span>
   <span class="font10">material </span>
   <span class="font10">new </span>
   <span class="font10">stages </span>
   <span class="font10">they </span>
   <span class="font10">using </span>
   <span class="font10">workers </span>
   <span class="font10">all </span>
   <span class="font10">medicinal </span>
   <span class="font10">most </span>
   <span class="font10">support </span>
   <span class="font10">through </span>
   <span class="font10">where </span>
   <span class="font10">Figure </span>
   <span class="font10">For </span>
   <span class="font10">Framework </span>
   <span class="font10">[], </span>
   <span class="font10">address </span>
   <span class="font10">applications </span>
   <span class="font10">applied </span>
   <span class="font10">current </span>
   <span class="font10">health </span>
   <span class="font10">human </span>
   <span class="font10">identification </span>
   <span class="font10">into </span>
   <span class="font10">nanomaterials </span>
   <span class="font10">only </span>
   <span class="font10">order </span>
   <span class="font10">physicochemical </span>
   <span class="font10">required </span>
   <span class="font10">requirements </span>
   <span class="font10">silico </span>
   <span class="font10">will </span>
   <span class="font10">(i.e., </span>
   <span class="font10">Exposure </span>
   <span class="font10">However, </span>
   <span class="font10">MDs </span>
   <span class="font10">NMs </span>
   <span class="font10">Regulation </span>
   <span class="font10">Sci. </span>
   <span class="font10">appropriate </span>
   <span class="font10">benefit-risk </span>
   <span class="font10">devices </span>
   <span class="font10">fate </span>
   <span class="font10">needed </span>
   <span class="font10">processes </span>
   <span class="font10">tools </span>
   <span class="font10">waste </span>
   <span class="font10">Chemicals </span>
   <span class="font10">Food </span>
   <span class="font10">Medicinal </span>
   <span class="font10">Nanoparticles </span>
   <span class="font10">REACH </span>
   <span class="font10">SbMD </span>
   <span class="font10">Testing </span>
   <span class="font10">adequate </span>
   <span class="font10">characterisation </span>
   <span class="font10">could </span>
   <span class="font10">described </span>
   <span class="font10">early </span>
   <span class="font10">environment </span>
   <span class="font10">include </span>
   <span class="font10">modelling </span>
   <span class="font10">other </span>
   <span class="font10">potential </span>
   <span class="font10">strategies </span>
   <span class="font10">studies </span>
   <span class="font10">test </span>
   <span class="font10">then </span>
   <span class="font10">within </span>
   <span class="font10">Advanced </span>
   <span class="font10">Development </span>
   <span class="font10">Products </span>
   <span class="font10">al., </span>
   <span class="font10">applicable </span>
   <span class="font10">assess </span>
   <span class="font10">assessed </span>
   <span class="font10">decision </span>
   <span class="font10">drug </span>
   <span class="font10">first </span>
   <span class="font10">needs </span>
   <span class="font10">phase, </span>
   <span class="font10">project </span>
   <span class="font10">same </span>
   <span class="font10">several </span>
   <span class="font10">stage </span>
   <span class="font10">systems </span>
   <span class="font10">tests </span>
   <span class="font10">therefore </span>
   <span class="font10">treatment </span>
   <span class="font10">when </span>
   <span class="font10">ATMP, </span>
   <span class="font10">ATMP. </span>
   <span class="font10">Analysis </span>
   <span class="font10">Commission </span>
   <span class="font10">Council </span>
   <span class="font10">Directive </span>
   <span class="font10">NBMs. </span>
   <span class="font10">Occupational </span>
   <span class="font10">Research </span>
   <span class="font10">Therefore, </span>
   <span class="font10">adopted </span>
   <span class="font10">adverse </span>
   <span class="font10">along </span>
   <span class="font10">alternative </span>
   <span class="font10">any </span>
   <span class="font10">application </span>
   <span class="font10">between </span>
   <span class="font10">implementation </span>
   <span class="font10">may </span>
   <span class="font10">means </span>
   <span class="font10">more </span>
   <span class="font10">patient </span>
   <span class="font10">performed </span>
   <span class="font10">processing </span>
   <span class="font10">production </span>
   <span class="font10">provide </span>
   <span class="font10">px; </span>
   <span class="font10">release </span>
   <span class="font10">results </span>
   <span class="font10">scenarios </span>
   <span class="font10">scientific </span>
   <span class="font10">set </span>
   <span class="font10">strategy </span>
   <span class="font10">type </span>
   <span class="font10">{font-family </span>
   <span class="font10">(EC) </span>
   <span class="font10">... </span>
   <span class="font10">Belgium </span>
   <span class="font10">Methodology </span>
   <span class="font10">Models </span>
   <span class="font10">Regulatory </span>
   <span class="font10">Strategy </span>
   <span class="font10">Workshop </span>
   <span class="font10">about </span>
   <span class="font10">animal </span>
   <span class="font10">assessment. </span>
   <span class="font10">associated </span>
   <span class="font10">biological </span>
   <span class="font10">compared </span>
   <span class="font10">complex </span>
   <span class="font10">concentrations </span>
   <span class="font10">concern </span>
   <span class="font10">considered </span>
   <span class="font10">efforts </span>
   <span class="font10">flow </span>
   <span class="font10">font-size </span>
   <span class="font10">guidance </span>
   <span class="font10">hazardous </span>
   <span class="font10">important </span>
   <span class="font10">intended </span>
   <span class="font10">market </span>
   <span class="font10">phase </span>
   <span class="font10">properly </span>
   <span class="font10">properties </span>
   <span class="font10">quality </span>
   <span class="font10">requires </span>
   <span class="font10">standards </span>
   <span class="font10">toxicological </span>
   <span class="font10">user </span>
   <span class="font10">//EC </span>
   <span class="font10">ATMPs </span>
   <span class="font10">Approaches </span>
   <span class="font10">Co-operation </span>
   <span class="font10">Control </span>
   <span class="font10">Dermal </span>
   <span class="font10">Economic </span>
   <span class="font10">Environ. </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">International </span>
   <span class="font10">Journal </span>
   <span class="font10">Modeling </span>
   <span class="font10">Moreover, </span>
   <span class="font10">NBM-based </span>
   <span class="font10">NBM. </span>
   <span class="font10">Nanomaterial </span>
   <span class="font10">Organisation </span>
   <span class="font10">Process </span>
   <span class="font10">Risks </span>
   <span class="font10">SbD </span>
   <span class="font10">Section </span>
   <span class="font10">Table </span>
   <span class="font10">Therapy </span>
   <span class="font10">UnionBrussels, </span>
   <span class="font10">Used </span>
   <span class="font10">Vitro </span>
   <span class="font10">according </span>
   <span class="font10">across </span>
   <span class="font10">adequately </span>
   <span class="font10">built </span>
   <span class="font10">concerns </span>
   <span class="font10">considering </span>
   <span class="font10">controls </span>
   <span class="font10">design </span>
   <span class="font10">discovery </span>
   <span class="font10">double; </span>
   <span class="font10">each </span>
   <span class="font10">effects </span>
   <span class="font10">endpoints </span>
   <span class="font10">expected </span>
   <span class="font10">explosion </span>
   <span class="font10">exposed </span>
   <span class="font10">following </span>
   <span class="font10">further </span>
   <span class="font10">guidelines </span>
   <span class="font10">intrinsic </span>
   <span class="font10">investigated </span>
   <span class="font10">known </span>
   <span class="font10">level </span>
   <span class="font10">made </span>
   <span class="font10">main </span>
   <span class="font10">model </span>
   <span class="font10">parameters </span>
   <span class="font10">performance </span>
   <span class="font10">personal </span>
   <span class="font10">pre-clinical </span>
   <span class="font10">products. </span>
   <span class="font10">provided </span>
   <span class="font10">raw </span>
   <span class="font10">recommended </span>
   <span class="font10">related </span>
   <span class="font10">risks, </span>
   <span class="font10">selection </span>
   <span class="font10">suitable </span>
   <span class="font10">time </span>
   <span class="font10">toxicology </span>
   <span class="font10">unintentional </span>
   <span class="font10">was </span>
   <span class="font10">&amp;amp; </span>
   <span class="font10">ATMPs. </span>
   <span class="font10">Amending </span>
   <span class="font10">Applications </span>
   <span class="font10">Approach </span>
   <span class="font10">Authorisation </span>
   <span class="font10">Based </span>
   <span class="font10">Chemical </span>
   <span class="font10">Design </span>
   <span class="font10">EMA </span>
   <span class="font10">Effects </span>
   <span class="font10">FDA </span>
   <span class="font10">Human </span>
   <span class="font10">IATA </span>
   <span class="font10">MFA </span>
   <span class="font10">Material </span>
   <span class="font10">Once </span>
   <span class="font10">Organization </span>
   <span class="font10">Parliament </span>
   <span class="font10">Pharmaceutical </span>
   <span class="font10">R&amp;amp;D </span>
   <span class="font10">Science </span>
   <span class="font10">September </span>
   <span class="font10">Soil </span>
   <span class="font10">Standardization </span>
   <span class="font10">Switzerland </span>
   <span class="font10">USA </span>
   <span class="font10">Using </span>
   <span class="font10">Workers </span>
   <span class="font10">[,,]. </span>
   <span class="font10">above </span>
   <span class="font10">accidental </span>
   <span class="font10">achieved </span>
   <span class="font10">activities </span>
   <span class="font10">addition, </span>
   <span class="font10">advanced </span>
   <span class="font10">analysis, </span>
   <span class="font10">assays </span>
   <span class="font10">assessing </span>
   <span class="font10">assessment, </span>
   <span class="font10">authors </span>
   <span class="font10">background </span>
   <span class="font10">balance </span>
   <span class="font10">because </span>
   <span class="font10">being </span>
   <span class="font10">bio-corona </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">complexity </span>
   <span class="font10">conceptual </span>
   <span class="font10">currently </span>
   <span class="font10">derived </span>
   <span class="font10">effective </span>
   <span class="font10">efficacy </span>
   <span class="font10">enable </span>
   <span class="font10">end-of-life </span>
   <span class="font10">ensure </span>
   <span class="font10">equipment </span>
   <span class="font10">evaluated </span>
   <span class="font10">example, </span>
   <span class="font10">experimental </span>
   <span class="font10">full </span>
   <span class="font10">handling </span>
   <span class="font10">high </span>
   <span class="font10">how </span>
   <span class="font10">identified </span>
   <span class="font10">identify </span>
   <span class="font10">importance </span>
   <span class="font10">includes </span>
   <span class="font10">industry </span>
   <span class="font10">innovation </span>
   <span class="font10">integrate </span>
   <span class="font10">interactions </span>
   <span class="font10">involve </span>
   <span class="font10">list </span>
   <span class="font10">measurement </span>
   <span class="font10">measurements </span>
   <span class="font10">measures, </span>
   <span class="font10">measures. </span>
   <span class="font10">might </span>
   <span class="font10">minimisation </span>
   <span class="font10">mode </span>
   <span class="font10">must </span>
   <span class="font10">nano-enabled </span>
   <span class="font10">non-clinical </span>
   <span class="font10">number </span>
   <span class="font10">online: </span>
   <span class="font10">out </span>
   <span class="font10">particle </span>
   <span class="font10">potentially </span>
   <span class="font10">presented </span>
   <span class="font10">procedures </span>
   <span class="font10">proposed </span>
   <span class="font10">protection </span>
   <span class="font10">read-across </span>
   <span class="font10">reduction </span>
   <span class="font10">require </span>
   <span class="font10">review </span>
   <span class="font10">risks. </span>
   <span class="font10">robust </span>
   <span class="font10">safer </span>
   <span class="font10">since </span>
   <span class="font10">solid; </span>
   <span class="font10">stakeholders </span>
   <span class="font10">target </span>
   <span class="font10">technical </span>
   <span class="font10">than </span>
   <span class="font10">therapeutic </span>
   <span class="font10">those </span>
   <span class="font10">throughout </span>
   <span class="font10">tier </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(EU) </span>
   <span class="font10">(ISO)ISO </span>
   <span class="font10">(cf. </span>
   <span class="font10">ATEX </span>
   <span class="font10">AgencyLondon, </span>
   <span class="font10">Assess </span>
   <span class="font10">Case </span>
   <span class="font10">ECHA </span>
   <span class="font10">ENMs </span>
   <span class="font10">Emissions </span>
   <span class="font10">Enchytraeus </span>
   <span class="font10">Evaluation, </span>
   <span class="font10">Flow </span>
   <span class="font10">France </span>
   <span class="font10">Future </span>
   <span class="font10">Handling </span>
   <span class="font10">Hazard </span>
   <span class="font10">Health./ijerph </span>
   <span class="font10">Horizon </span>
   <span class="font10">IATA, </span>
   <span class="font10">IATAs </span>
   <span class="font10">InhalationDermal </span>
   <span class="font10">L.P. </span>
   <span class="font10">Life </span>
   <span class="font10">NBM, </span>
   <span class="font10">NBMs, </span>
   <span class="font10">November </span>
   <span class="font10">OECD </span>
   <span class="font10">Particle </span>
   <span class="font10">Practice </span>
   <span class="font10">Probabilistic </span>
   <span class="font10">Public </span>
   <span class="font10">Res. </span>
   <span class="font10">Stakeholder </span>
   <span class="font10">Such </span>
   <span class="font10">System </span>
   <span class="font10">Technol../acs.est.b </span>
   <span class="font10">Toxicol. </span>
   <span class="font10">United </span>
   <span class="font10">Use </span>
   <span class="font10">[,,,]. </span>
   <span class="font10">action </span>
   <span class="font10">adapted </span>
   <span class="font10">additional </span>
   <span class="font10">addressed </span>
   <span class="font10">already </span>
   <span class="font10">analysers </span>
   <span class="font10">analytical </span>
   <span class="font10">areas </span>
   <span class="font10">bold </span>
   <span class="font10">case </span>
   <span class="font10">compartments </span>
   <span class="font10">concept </span>
   <span class="font10">cost </span>
   <span class="font10">courier; </span>
   <span class="font10">decisions </span>
   <span class="font10">depending </span>
   <span class="font10">designed </span>
   <span class="font10">develop </span>
   <span class="font10">e.g., </span>
   <span class="font10">ecological </span>
   <span class="font10">efficient </span>
   <span class="font10">em; </span>
   <span class="font10">evaluation </span>
   <span class="font10">existing </span>
   <span class="font10">facilitate </span>
   <span class="font10">far </span>
   <span class="font10">final </span>
   <span class="font10">flows </span>
   <span class="font10">form </span>
   <span class="font10">generally </span>
   <span class="font10">goal </span>
   <span class="font10">guide </span>
   <span class="font10">help </span>
   <span class="font10">highly </span>
   <span class="font10">however </span>
   <span class="font10">identifying </span>
   <span class="font10">impact </span>
   <span class="font10">improve </span>
   <span class="font10">increased </span>
   <span class="font10">involved </span>
   <span class="font10">involving </span>
   <span class="font10">issues </span>
   <span class="font10">its </span>
   <span class="font10">like </span>
   <span class="font10">many </span>
   <span class="font10">media </span>
   <span class="font10">medicine. </span>
   <span class="font10">minimise </span>
   <span class="font10">minimum </span>
   <span class="font10">nano-bio </span>
   <span class="font10">nano-biomaterials </span>
   <span class="font10">nature </span>
   <span class="font10">optimised </span>
   <span class="font10">paper </span>
   <span class="font10">part </span>
   <span class="font10">participants </span>
   <span class="font10">pharmaceutical </span>
   <span class="font10">pharmacovigilance </span>
   <span class="font10">phases </span>
   <span class="font10">pilot </span>
   <span class="font10">plan </span>
   <span class="font10">plant </span>
   <span class="font10">post-marketing </span>
   <span class="font10">principles </span>
   <span class="font10">products, </span>
   <span class="font10">professionals </span>
   <span class="font10">provides </span>
   <span class="font10">pt;} </span>
   <span class="font10">purpose </span>
   <span class="font10">regulations </span>
   <span class="font10">released </span>
   <span class="font10">risk-benefit </span>
   <span class="font10">sortingPacking/re-packing </span>
   <span class="font10">steps </span>
   <span class="font10">steps, </span>
   <span class="font10">structured </span>
   <span class="font10">synthesis </span>
   <span class="font10">targeted </span>
   <span class="font10">terms </span>
   <span class="font10">testing, </span>
   <span class="font10">testing. </span>
   <span class="font10">therapy </span>
   <span class="font10">three </span>
   <span class="font10">toxic </span>
   <span class="font10">toxicity </span>
   <span class="font10">two </span>
   <span class="font10">upon </span>
   <span class="font10">wastewater </span>
   <span class="font10">working </span>
   <span class="font10">yet </span>
  </p>
 </body>
</html>
